NuvaRing Birth Control Blood Clot Risk
The lawyers at Saiontz & Kirk, P.A. represent women throughout the United States who are pursuing a NuvaRing lawsuit over blood clots caused by popular birth control ring. Recent data from a federally-funded study provides further support for these claims, suggesting that side effects of NuvaRing increase the risk of blood clots, pulmonary embolism and deep vein thrombosis when compared to women who took an older oral birth control.
Please note that the lawyers at Saiontz & Kirk, P.A. are no longer taking on new cases involving NuvaRing. The content on this page is provided for informational purposes only.
Researchers with the FDA, Kaiser Permanent, Vanderbilt University and the University of Washington found that women who used NuvaRing were 56% more likely to suffer blood clots and venous thomboembolic events (VTEs), according to data released (PDF) by the FDA in October 2011.
The study evaluated medical data on about 800,000 women from 2001 to 2007. Not only did researchers identifiy an increased risk of NuvaRing blood clots, but also found an increased risk of heart attacks and strokes with the newer birth control product.
NuvaRing is a one-monthly device that is inserted into the vagina to prevent pregnancy. The device releases a stream of ethinyl estradiol (EE) and etonogestrel for three weeks. Etonogestral is known as a “third generation” progestin, and has been linked to several health concerns.
While the manufacturers have suggested that the risk of blood clots from NuvaRing is similar to that found with birth control pills, it appears that women are exposed to higher levels of estrogen than provided by some oral contraceptives, which could be partially responsible for the increased blood clot risk with NuvaRing birth control.
NUVARING BLOOD CLOT LAWSUIT
As a result of the drug maker’s failure to adequately research the birth control ring or warn about the extent of the NuvaRing blood clot risk, financial compensation may be available for women who have experienced a:
- Pulmonary Embolism
- Deep Vein Thrombosis (DVT)
- Heart Attack
- Sudden Death
Free consultations and claim evaluations were previously being provided to help women and their families determine if they may be eligible for a NuvaRing blood clot lawsuit. All cases are pursued through a contingency fee, which means that there are never any out-of-pocket expenses for our NuvaRing law firm to represent you and we receive no attorney fees unless we obtain a recovery.
NuvaRing cases are no longer being accepted